đŹ Current Disease Focus:
Task Progress: 0%
đ„ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
đ§Ș Experimental Design
đŹ Clinical Trials
đ Treatment Development
This is an efficacy and safety study to compare aprepitant with ondansetron...
Status
Completed
Location
Multiple Locations
Start Date
2012-12-12
Trial ID
NCT01636947
The purpose of this study is to compare a standard chemotherapy regimen of ...
Status
Unknown
Location
112 sites UK wide
Start Date
2010-05
Trial ID
NCT01554852
Treatments Being Tested
The primary objective of this study was to compare progression-free surviva...
Status
Completed
Location
Providence St. Joseph Medical Center
Start Date
2012-06-20
Trial ID
NCT01568866
Treatments Being Tested
Chemotherapy-induced nausea and vomiting is a common side effect of cancer ...
Status
Completed
Location
Fifth Affilliated Hospital of Sun Yat-sen University
Start Date
2020-02-03
Trial ID
NCT04437017
Treatments Being Tested
This is a Phase 1 clinical trial to evaluate a new combination of drugs for...
Status
Completed
Location
University of Chicago Medical Center
Start Date
2014-06-05
Trial ID
NCT02103335
Treatments Being Tested
The primary purpose of this study is to compare the efficacy of daratumumab...
Status
Completed
Location
Peking Union Medical College Hospital
Start Date
2017-11-30
Trial ID
NCT03234972
Treatments Being Tested
This trial will study how safely the tazemetostat works with other therapie...
Status
Withdrawn
Location
California Cancer Associates For Research And Excellence, cCARE
Start Date
2021-12-22
Trial ID
NCT05205252
Thalidomide-Dexamethasone (TD) is a standard induction therapy for Multiple...
Status
Unknown
Location
AOU di Bologna Policlinico S.Orsola-Malpighi, UO di Ematologia
Start Date
2006-05
Trial ID
NCT01134484
Carboplatin, nab-paclitaxel, and nivolumab combination will be administered...
Status
Completed
Location
University of Chicago Medical Center
Start Date
2017-06-27
Trial ID
NCT03107182
A Phase 2, open-label, dose escalation study to evaluate the safety and eff...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham - Main /ID# 151405
Start Date
2017-01-19
Trial ID
NCT02899052
Treatments Being Tested